AR069727A1 - ISOLATED COMPOUND DERIVED FROM ALFA / BETA D-GLUCOPIRANOSA, AN INDUCTIVE COMPOSITION OF THE PLANTS DEFENSE MECHANISM, A METHOD FOR INDUCIATING SUCH MECHANISM, A METHOD FOR THE TREATMENT OF INFECTED PLANTS, A PROCEDURE FOR OBTAINING UNDERTAKEN INDUCT - Google Patents
ISOLATED COMPOUND DERIVED FROM ALFA / BETA D-GLUCOPIRANOSA, AN INDUCTIVE COMPOSITION OF THE PLANTS DEFENSE MECHANISM, A METHOD FOR INDUCIATING SUCH MECHANISM, A METHOD FOR THE TREATMENT OF INFECTED PLANTS, A PROCEDURE FOR OBTAINING UNDERTAKEN INDUCTInfo
- Publication number
- AR069727A1 AR069727A1 ARP080103098A AR069727A1 AR 069727 A1 AR069727 A1 AR 069727A1 AR P080103098 A ARP080103098 A AR P080103098A AR 069727 A1 AR069727 A1 AR 069727A1
- Authority
- AR
- Argentina
- Prior art keywords
- galoyl
- groups
- plants
- hhdp
- group
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 230000008260 defense mechanism Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 3
- 230000001939 inductive effect Effects 0.000 title 1
- 230000007246 mechanism Effects 0.000 title 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 abstract 5
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 229960002246 beta-d-glucopyranose Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Compuestos aislados derivados de alfa/beta-D-glucopiranosa pueden tener la formula general (1) en donde R1 es un derivado del ácido benzoico di o tri hidroxilado; R2 es H o un derivado del ácido benzoico di o tri hidroxilado, R3 es H o un derivado del ácido benzoico di o tri hidroxilado; R4 es H o un derivado del ácido benzoico di o tri hidroxilado, y R5 es H o un derivado del ácido benzoico di o tri hidroxilado, en donde cuando R1 y R2 son dos grupos galoilos, R1 y R2 pueden ser un grupo hexahidroxidifenoil (HHDP); cuando R2 y R3 son dos grupos galoilos, R2 y R3 pueden ser un grupo HHDP; cuando R3 y R4 son dos grupos galoilos, R3 y R4 pueden ser un grupo HHDP; cuando R4 y R5 son dos grupos galoilos, R4 y R5 pueden ser un grupo HHDP; cuando R1 y R3 son dos grupos galoilos, R1 y R3 pueden ser un grupo HHDP; cuando R1 y R4 son dos grupos galoilos, R1 y R4 pueden ser un grupo HHDP, cuando R1 y R5 son dos grupos galoilos, R1 y R5 pueden ser un grupo HHDP; cuando R2 y R4 son des grupos galoilos, R2 y R4 pueden ser un grupo HHDP, cuando R2 y R5 son dos grupos galoilos, R2 y R5 pueden ser un grupo HHDP; cuando R3 y R5 son dos grupos galoilos, R3 y R5 pueden ser un grupo HHDP. Por ejemplo compuestos tales como1-()-dihidroxifenoil-?/?-D-glucopiranosa o 1-()-galoil-2,3,4,6-biHHDP-?/?-D-glucopiranosa. Los compuestos inducen mecanismos de defensa de las plantas, y pueden utilizarse en la elaboracion de composiciones utiles en el tratamiento y prevencion de enfermedades de plantas.Isolated compounds derived from alpha / beta-D-glucopyranose may have the general formula (1) wherein R 1 is a derivative of di or tri hydroxylated benzoic acid; R2 is H or a derivative of di or tri hydroxylated benzoic acid, R3 is H or a derivative of di or tri hydroxylated benzoic acid; R4 is H or a derivative of di or tri hydroxylated benzoic acid, and R5 is H or a derivative of di or tri hydroxylated benzoic acid, where when R1 and R2 are two galoyl groups, R1 and R2 can be a hexahydroxidiphenyl (HHDP) group ); when R2 and R3 are two galoyl groups, R2 and R3 can be an HHDP group; when R3 and R4 are two galoyl groups, R3 and R4 can be an HHDP group; when R4 and R5 are two galoyl groups, R4 and R5 can be an HHDP group; when R1 and R3 are two galoyl groups, R1 and R3 can be an HHDP group; when R1 and R4 are two galoyl groups, R1 and R4 can be an HHDP group, when R1 and R5 are two galoyl groups, R1 and R5 can be an HHDP group; when R2 and R4 are galoyl groups, R2 and R4 can be an HHDP group, when R2 and R5 are two galoyl groups, R2 and R5 can be an HHDP group; when R3 and R5 are two galoyl groups, R3 and R5 can be an HHDP group. For example compounds such as 1- () - dihydroxyphenoyl -? /? - D-glucopyranoside or 1- () - galloyl-2,3,4,6-biHHDP -? /? - D-glucopyranoside. The compounds induce defense mechanisms of plants, and can be used in the elaboration of useful compositions in the treatment and prevention of plant diseases.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP080103098 AR069727A1 (en) | 2008-07-18 | 2008-07-18 | ISOLATED COMPOUND DERIVED FROM ALFA / BETA D-GLUCOPIRANOSA, AN INDUCTIVE COMPOSITION OF THE PLANTS DEFENSE MECHANISM, A METHOD FOR INDUCIATING SUCH MECHANISM, A METHOD FOR THE TREATMENT OF INFECTED PLANTS, A PROCEDURE FOR OBTAINING UNDERTAKEN INDUCT |
| MX2009007715A MX2009007715A (en) | 2008-07-18 | 2009-07-17 | Compounds and compositions for inducing defence mechanisms in plants, methods and application, obtention process, extracts and uses thereof. |
| BRPI0902598A BRPI0902598B1 (en) | 2008-07-18 | 2009-07-17 | method for inducing a plant defense mechanism against pathogens, use of a compound and use of the compound 1-o-gallon-2,3; 4,6-bis-hhdp-a / ß-d-glycopyranose |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP080103098 AR069727A1 (en) | 2008-07-18 | 2008-07-18 | ISOLATED COMPOUND DERIVED FROM ALFA / BETA D-GLUCOPIRANOSA, AN INDUCTIVE COMPOSITION OF THE PLANTS DEFENSE MECHANISM, A METHOD FOR INDUCIATING SUCH MECHANISM, A METHOD FOR THE TREATMENT OF INFECTED PLANTS, A PROCEDURE FOR OBTAINING UNDERTAKEN INDUCT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR069727A1 true AR069727A1 (en) | 2010-02-17 |
Family
ID=41727455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080103098 AR069727A1 (en) | 2008-07-18 | 2008-07-18 | ISOLATED COMPOUND DERIVED FROM ALFA / BETA D-GLUCOPIRANOSA, AN INDUCTIVE COMPOSITION OF THE PLANTS DEFENSE MECHANISM, A METHOD FOR INDUCIATING SUCH MECHANISM, A METHOD FOR THE TREATMENT OF INFECTED PLANTS, A PROCEDURE FOR OBTAINING UNDERTAKEN INDUCT |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR069727A1 (en) |
| BR (1) | BRPI0902598B1 (en) |
| MX (1) | MX2009007715A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102887924A (en) * | 2012-10-24 | 2013-01-23 | 天津科技大学 | Preparation of active components for tyrosinase inhibition from agricultural and forestry waste walnut shell and application of active components |
| CN106432374B (en) * | 2016-09-07 | 2018-11-23 | 海南医学院 | A kind of ester glycosides and its application |
-
2008
- 2008-07-18 AR ARP080103098 patent/AR069727A1/en unknown
-
2009
- 2009-07-17 BR BRPI0902598A patent/BRPI0902598B1/en not_active IP Right Cessation
- 2009-07-17 MX MX2009007715A patent/MX2009007715A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0902598A2 (en) | 2010-06-08 |
| BRPI0902598B1 (en) | 2017-04-04 |
| MX2009007715A (en) | 2010-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX348445B (en) | COMPOSITION FOR THE CONTROL OF DISEASES IN PLANTS AND METHOD TO CONTROL DISEASES IN PLANTS THROUGH THE APPLICATION OF THE COMPOSITION. | |
| ECSP21080528A (en) | ANTIVIRAL COMPOUNDS CONTAINING NITRILE | |
| CO2022002804A2 (en) | Piperidinyl-methyl-purinamines as nsd2 inhibitors and antineoplastics | |
| MX2009008439A (en) | Novel inhibitors hepatitis c virus replication. | |
| ECSP066570A (en) | MACROCYCLIC AND ACILSULPHONAMID CARBOXYLIC ACIDS AS HCV REPLICATION INHIBITORS | |
| PE20191541A1 (en) | COMPOSITIONS AND METHODS TO INHIBIT THE ACTION OF ARGINASE | |
| PE20140171A1 (en) | FUNGICIDE PYRAZOLES AND THEIR MIXTURES | |
| MA32231B1 (en) | Organic compounds | |
| CO2019003482A2 (en) | Compounds derived from cyclobutane or azetidine 1,3 substituted as hematopoietic prostaglandin d synthase inhibitors | |
| BR112012014899A2 (en) | compound, pharmaceutical composition, method for treating or preventing hepatitis c virus infection in a subject, method for treating, preventing or ameliorating one or more symptoms of a liver disease or disorder associated with hepatitis c virus infection in a subject , method for inhibiting replication of a virus in a host, method for inhibiting replication of a virus | |
| DK2203430T3 (en) | N-phenyl-dioxo-hydropyrimidines useful as inhibitors of hepatitis C virus (HCV) | |
| UA108219C2 (en) | ANTI-PARASITER DIGIDROAZOLE COMPOUNDS AND COMPOSITION CONTAINING THEM (OPTIONS) | |
| CL2008003431A1 (en) | 2 ', 4' substituted nucleoside derived compounds; process of preparation of said compounds; pharmaceutical composition comprising them; its method of preparation; and its use for the treatment and / or prevention of any condition resulting from an infection by hiv, hiv or hiv. | |
| MX2010005292A (en) | Inhibitors of human immunodeficiency virus replication. | |
| AR070299A1 (en) | DERIVATIVES OF PIRAZOLOPIRIMIDINAS AS INHIBITORS OF CYCLININE DEPENDENT KINASES, USES AND PHARMACEUTICAL COMPOSITIONS | |
| UY30809A1 (en) | DERIVATIVES OF N- [3- [4-PHENYL) PIPERIDIN-1-CARBONIL] PHENYL] SUBSTITUTED SULFONAMIDS, PREPARATION PROCESSES AND APPLICATIONS | |
| AR053162A1 (en) | COMPOUND 5 - OXO - REPLACED PIRROLIDIN, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A MEDICINAL PRODUCT FOR THE TREATMENT OF GLAUCOMA. | |
| CL2013002299A1 (en) | Compounds derived from heterocycles, inhibitors of hepatitis c virus replication; pharmaceutical composition comprising them; useful in the treatment of an infection by hcv. (divisional application 689-2011). | |
| AR055095A1 (en) | NEW MACROCICLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | |
| AR102467A1 (en) | METHODS TO TREAT INFECTIONS BY VIRUS FILOVIRIDAE | |
| ECSP099780A (en) | NEW MACROCICLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | |
| ECSP066383A (en) | DERIVATIVES OF 5-PHENYL-4-METHYL-TIAZOL-2-IL-AMINA AS INHIBITORS OF KINASA ENZYMES PHOSFATIDILINOSITOL 3 (PI3) FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE RESPIRATORY ROUTES | |
| UY32582A (en) | 3 KINASE PHOSPHINOSITI INHIBITORS AND / OR MAMMAL OBJECTIVE | |
| CL2008002330A1 (en) | Compounds derived from 1-phenyl-2-pyridinylalkyl alcohols, inhibitors of phosphodiesterase 4 (pde4); process of preparation of said compounds; pharmaceutical compositions containing them; and its use to prepare useful medications in the prevention or treatment of asthma, chronic bronchitis and COPD. | |
| MX2009000657A (en) | Compositions and methods for the treatment of mucositis. |